诚意药业
(603811)
| 流通市值：26.05亿 | | | 总市值：26.05亿 |
| 流通股本：3.27亿 | | | 总股本：3.27亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 251,962,998.95 | 294,140,846.4 | 309,113,068.94 | 267,284,612.63 |
| 应收票据及应收账款 | 64,681,142.41 | 76,768,569.65 | 45,833,618.73 | 54,166,990.12 |
| 应收账款 | 64,681,142.41 | 76,768,569.65 | 45,833,618.73 | 54,166,990.12 |
| 应收款项融资 | 27,442,149.44 | 16,410,191.66 | 30,557,058.45 | 22,504,578.53 |
| 预付款项 | 11,729,586.41 | 7,978,727.11 | 6,985,903.94 | 7,455,753.36 |
| 其他应收款合计 | 3,006,558.52 | 2,872,417.83 | 1,982,164.66 | 12,848,654.71 |
| 应收股利 | - | - | - | 11,250,500 |
| 存货 | 137,215,791.4 | 116,781,938.02 | 120,212,190.72 | 105,193,704 |
| 其他流动资产 | 166,124.74 | 2,471,732.52 | 5,274,866.86 | 4,949,761.75 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 496,204,351.87 | 517,424,423.19 | 519,958,872.3 | 474,404,055.1 |
| 非流动资产: | | | | |
| 长期股权投资 | 291,513,548.02 | 281,131,978.88 | 272,632,556.56 | 262,341,986.55 |
| 投资性房地产 | 1,080,809.38 | 1,110,834.85 | 1,140,860.32 | 1,170,885.79 |
| 固定资产 | 973,621,716.99 | 995,240,762.07 | 694,273,692.58 | 703,411,622.24 |
| 在建工程 | 6,407,555.4 | 6,157,940.16 | 238,627,203.25 | 234,374,757.93 |
| 使用权资产 | 1,048,730.84 | 1,232,490.02 | 1,437,098.56 | 1,643,358.65 |
| 无形资产 | 85,894,555.51 | 66,659,113.38 | 66,306,800.6 | 67,016,606.03 |
| 长期待摊费用 | 1,269,895.81 | 1,430,646.96 | 1,654,686.87 | 1,327,097.54 |
| 递延所得税资产 | 5,509,366.73 | 5,943,489.02 | 10,707,806.76 | 12,984,986.54 |
| 其他非流动资产 | 14,750,309.6 | 16,434,234.2 | 27,240,884.4 | 32,498,064.96 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,381,096,488.28 | 1,375,341,489.54 | 1,314,021,589.9 | 1,316,769,366.23 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,877,300,840.15 | 1,892,765,912.73 | 1,833,980,462.2 | 1,791,173,421.33 |
| 流动负债: | | | | |
| 短期借款 | 103,097,666.66 | 117,326,855.55 | 190,138,430.57 | 163,629,803.62 |
| 应付票据及应付账款 | 91,304,027.97 | 118,912,785.04 | 51,474,799.11 | 55,390,307.94 |
| 应付账款 | 91,304,027.97 | 118,912,785.04 | 51,474,799.11 | 55,390,307.94 |
| 合同负债 | 6,201,806.87 | 4,375,548.86 | 6,014,901.15 | 10,585,302.69 |
| 应付职工薪酬 | 16,171,280.32 | 22,486,884.08 | 11,260,881.57 | 9,291,420.45 |
| 应交税费 | 9,996,870.1 | 13,312,053.06 | 8,535,427.7 | 11,465,888.27 |
| 其他应付款合计 | 58,838,069.18 | 55,938,679.92 | 63,185,186.16 | 59,582,434.93 |
| 一年内到期的非流动负债 | 9,554,238.34 | 9,663,255.44 | 1,005,738.9 | 1,005,304.22 |
| 其他流动负债 | 786,208.62 | 632,038.75 | 780,805.82 | 1,129,147.28 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 295,950,168.06 | 342,648,100.7 | 332,396,170.98 | 312,079,609.4 |
| 非流动负债: | | | | |
| 长期借款 | 316,363,014.42 | 316,379,717.98 | 318,871,293.25 | 318,890,950.36 |
| 租赁负债 | 465,771.99 | 470,214.19 | 537,237.79 | 942,292.93 |
| 递延收益 | 20,204,602.86 | 21,286,105.62 | 17,801,880.63 | 17,679,651.55 |
| 递延所得税负债 | 14,961,340.25 | 15,369,795.02 | 16,304,588 | 16,723,939.68 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 351,994,729.52 | 353,505,832.81 | 353,514,999.67 | 354,236,834.52 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 647,944,897.58 | 696,153,933.51 | 685,911,170.65 | 666,316,443.92 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 327,304,320 | 327,304,320 | 327,304,320 | 327,304,320 |
| 资本公积 | 142,998,487.16 | 142,998,487.16 | 142,998,487.16 | 142,998,487.16 |
| 其他综合收益 | 219,083.12 | 206,551.94 | 208,691.49 | 193,588.95 |
| 盈余公积 | 119,522,219.98 | 119,522,219.98 | 104,074,443.19 | 104,074,443.19 |
| 未分配利润 | 634,967,658.39 | 602,282,684.36 | 568,780,971.67 | 545,432,851.43 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,225,011,768.65 | 1,192,314,263.44 | 1,143,366,913.51 | 1,120,003,690.73 |
| 少数股东权益 | 4,344,173.92 | 4,297,715.78 | 4,702,378.04 | 4,853,286.68 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,229,355,942.57 | 1,196,611,979.22 | 1,148,069,291.55 | 1,124,856,977.41 |
| 负债和股东权益合计 | 1,877,300,840.15 | 1,892,765,912.73 | 1,833,980,462.2 | 1,791,173,421.33 |
| 公告日期 | 2024-04-26 | 2024-04-26 | 2023-10-27 | 2023-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |